Wordt geladen...
ESHAP salvage therapy for relapsed or refractory non-Hodgkin's lymphoma.
The ESHAP regimen, a combination of the chemotherapeutic drugs etoposide, methylprednisolone (solumedrol), high-dose cytarabine (ara-C), and cisplatin, has been shown to be active against refractory or relapsed non-Hodgkin's lymphoma (NHL) in therapeutic trials. We undertook this study to deter...
Bewaard in:
| Hoofdauteurs: | , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Korean Academy of Medical Sciences
2002
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3054931/ https://ncbi.nlm.nih.gov/pubmed/12378012 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|